Browse views: by Year, by Function, by GLF, by Subfunction, by Conference, by Journal

Relative bioavailability of deferasirox tablets administered without dispersion and dispersed in various drinks.

Séchaud, R and Dutreix, C and Balez, S and Pommier, F and Dumortier, T and Morisson, S and Brun, E (2008) Relative bioavailability of deferasirox tablets administered without dispersion and dispersed in various drinks. International journal of clinical pharmacology and therapeutics, 46 (2). pp. 102-108. ISSN 0946-1965

Abstract

Deferasirox (ExjadeA, ICL670) is a new, once-daily oral iron chelator, recently approved as first-line therapy in the treatment of iron overload resulting from blood transfusions. In registration studies, deferasirox tablets were dispersed in non-carbonated water prior to administration. In routine clinical practice, however, patients may prefer to take the tablet dispersed in a flavored drink rather than with water.

Item Type: Article
Date Deposited: 28 Jan 2012 00:45
Last Modified: 28 Jan 2012 00:45
URI: https://oak.novartis.com/id/eprint/5518

Search

Email Alerts

Register with OAK to receive email alerts for saved searches.